Jeff White

Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy

F. Reed Johnson, George Van Houtven, Semra Özdemir et al. · Journal of Neurology · 2009 · 125 citations

Pharmacy, Neurology, Patient Safety +11

Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation

Gboyega Adeboyeje, Gosia Sylwestrzak, John J. Barron et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 118 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis

Santosh Gautam, Abiy Agiro, John Barron et al. · Cardiovascular Diabetology · 2017 · 35 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16